FIELD: organic chemistry, medicine, ophthalmology, pharmacy.
SUBSTANCE: invention relates to new derivatives of nitrogen-containing heterocyclic compounds of the general formula (I): wherein X1, X2, X3, X4 and X5 mean -CH2 or one of them represents -NH and another X1-X5 represent -CH2; k = 0, 1 or 2; when t = 2, then radicals R1 are similar or different; R1 represents direct or branched (C1-C8)-alkyl or (C1-C8)-alkoxy-group; A means phenyl or pyridinyl; R2 means hydrogen atom (H), hydroxyl, halogen atom, (C1-C6)-alkyl, (C1-C6)-alkoxy-group; n = 0, 1-4; radicals R2 are similar or different, when n > 1; p = 0 or 1-5; Y means -OC(O); Z means -CH, or to their pharmaceutically acceptable salts. Compounds of the formula (I) possess agonistic activity with respect to muscarinic receptors and can be used in medicine as medicinal preparations for treatment of neurodegenerative diseases or diseases associated with increased intraocular pressure.
EFFECT: valuable medicinal properties of derivatives.
6 cl, 1 tbl, 2 dwg, 16 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2230740C2 |
MUSCARINIC AGONISTS | 2001 |
|
RU2269523C2 |
MUSCARINIC RECEPTOR AGONISTS | 2015 |
|
RU2678835C2 |
BICYCLIC HETEROCYCLIC SPIROCOMPOUNDS | 2010 |
|
RU2506266C2 |
DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
BICYCLIC NITROGEN-CONTAINING COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS | 2015 |
|
RU2685230C2 |
AZACYCLIC COMPOUNDS TO BE USED IN TREATING SEROTONIN-MEDIATED DISEASES | 2001 |
|
RU2398765C1 |
DIAMIDE COMPOUNDS HAVING ACTIVITY OF MUSCARINIC RECEPTOR ANTAGONIST AND ACTIVITY OF β ADRENERGIC RECEPTOR AGONIST | 2010 |
|
RU2676686C2 |
COMPOUNDS HAVING ANTAGONISTIC ACTIVITY TOWARDS MUSCARINIC RECEPTORS AND AGONIST ACTIVITY TO BETA2-ADRENORECEPTORS | 2012 |
|
RU2606121C2 |
PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
Authors
Dates
2006-06-20—Published
1999-03-31—Filed